Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL260684 | 0.77 | HPGD (0.42) | TDP1NPC1RAB9AKMT2ACA2 | |
| SCHEMBL2770669 | 0.77 | CA2 (0.40) | NPC1RAB9AMEN1KMT2ACA2 | |
| SCHEMBL67557 | 0.77 | ALDH1A1 (0.47) | CES2CES1KMT2ACA2CA4 | |
| SCHEMBL5811174 | 0.76 | GABRA1 (0.42) | MEN1KMT2ACA2CA4CA5A | |
| SCHEMBL2773100 | 0.76 | FOLH1 (0.46) | MEN1KMT2ACA2CA4CA5A | |
| SCHEMBL68471 | 0.73 | CA12 (0.56) | NPC1RAB9AMEN1KMT2ACA2 | |
| SCHEMBL31717959 | 0.73 | RAB9A (0.41) | TDP1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL6873921 | 0.73 | KMT2A (0.40) | NPC1RAB9AMEN1KMT2ACA2 | |
| SCHEMBL7862158 | 0.73 | CA12 (0.56) | NPC1RAB9AMEN1KMT2ACA2 | |
| SCHEMBL17446544 | 0.73 | CA2 (0.48) | CES2CES1NPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3960151-B1 | PHOTOCURABLE CYANOACRYLATE COMPOSITION WITH CONTROLLED EXOTHERM | CUANTUM MEDICAL COSMETICS S L (ES) | 2025-04-23 | — | — | EP | claimed |
| EP-3960151-A1 | PHOTOCURABLE CYANOACRYLATE COMPOSITION WITH CONTROLLED EXOTHERM | Cuantum Medical Cosmetics, S.L. (ES) | 2022-03-02 | — | — | EP | claimed |
| EP-3689338-A1 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | Oculeve, Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| EP-3110405-A2 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | Oculeve, Inc. (US) | 2017-01-04 | — | — | EP | claimed |
| WO-2015130707-A2 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE, INC. (US) | 2015-09-03 | — | — | WO | claimed |
| US-20150238754-A1 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE, INC. | 2015-08-27 | — | — | US | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | disclosed |
| WO-2025119863-A1 | PHOTOCURABLE COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE, N-HEXYLCYANOACRYLATE OR N-OCTYLCYANOACRYLATE | BOSTIK SA (FR) | 2025-06-12 | — | — | WO | disclosed |
| EP-4567051-A1 | PHOTOCURABLE COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE, N-HEXYLCYANOACRYLATE OR N-OCTYLCYANOACRYLATE | Bostik SA (FR) | 2025-06-11 | — | — | EP | disclosed |
| EP-3960151-B1 | PHOTOCURABLE CYANOACRYLATE COMPOSITION WITH CONTROLLED EXOTHERM | CUANTUM MEDICAL COSMETICS S L (ES) | 2025-04-23 | — | — | EP | disclosed |
| EP-4194523-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | Cuantum Medical Cosmetics, S.L. (ES) | 2023-06-14 | — | — | EP | disclosed |
| EP-3960151-A1 | PHOTOCURABLE CYANOACRYLATE COMPOSITION WITH CONTROLLED EXOTHERM | Cuantum Medical Cosmetics, S.L. (ES) | 2022-03-02 | — | — | EP | disclosed |
| US-20210069496-A1 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE INC (US) | 2021-03-11 | — | — | US | disclosed |
| US-9956397-B2 | Polymer Formulations for nasolacrimal stimulation | OCULEVE, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170368333-A1 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE, INC. | 2017-12-28 | — | — | US | disclosed |
| US-9770583-B2 | Polymer formulations for nasolacrimal stimulation | OCULEVE, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-9555583-B1 | Fabrication of neural interfaces using 3D projection micro-stereolithography | SANDIA CORPORATION (US) | 2017-01-31 | — | — | US | disclosed |
| EP-3110405-A2 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | Oculeve, Inc. (US) | 2017-01-04 | — | — | EP | disclosed |
| WO-2015130707-A2 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE, INC. (US) | 2015-09-03 | — | — | WO | disclosed |
| US-20150238754-A1 | POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION | OCULEVE, INC. | 2015-08-27 | — | — | US | disclosed |